Literature DB >> 2825515

Evaluation of diagnostic criteria for mucosal cytomegalic inclusion disease in the acquired immune deficiency syndrome.

J A Culpepper-Morgan1, D P Kotler, J V Scholes, A R Tierney.   

Abstract

Mucosal cytomegalic inclusion disease (CID) is a serious complication in acquired immune deficiency syndrome (AIDS) that usually is associated with disseminated cytomegalovirus (CMV) infection, and leads progressively to death in many patients. Early diagnosis may improve the chances of responding to specific antiviral therapy. We analyzed retrospectively the diagnostic evaluations of 26 AIDS patients with histopathologically confirmed CID infections and 19 AIDS or AIDS-related complex patients without CMV infections. The groups were similar demographically and clinically. Characteristic CMV inclusion bodies were found on antemortem biopsy in 92% of patients, including 80% for rectal biopsy alone. The specificity of the viral inclusions for CMV was established using an immunohistological technique. Rectal culture for virus isolation was much less sensitive (30%) than biopsy. Urine cultures were positive more frequently (39%) than were rectal cultures, but were less specific. Furthermore, the presence of immunoglobulin G anti-CMV was nonspecific and the presence of immunoglobulin anti-CMV was both insensitive and nonspecific. We conclude that mucosal biopsy is a rapid and reliable means of detecting cytomegalovirus infections, and is an indispensible part of the evaluation for this disease.

Entities:  

Mesh:

Year:  1987        PMID: 2825515

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

1.  Etiology and evaluation of diarrhea in AIDS:a global perspective at the millennium.

Authors:  C Mel Wilcox
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

2.  Multiple ulcers of the ileum due to Cytomegalovirus infection in a patient who showed no evidence of an immunocompromised state.

Authors:  S Taniwaki; M Kataoka; H Tanaka; Y Mizuno; M Hirose
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

3.  Cytomegalovirus infection causing an enterocutaneous fistula in a patient with acquired immunodeficiency syndrome.

Authors:  M L Borum
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

4.  Cytomegalovirus Colitis, Cytomegalovirus Hepatitis and Systemic Cytomegalovirus Infection: Common Features and Differences.

Authors:  Hiroshi Nakase; Hans Herfarth
Journal:  Inflamm Intest Dis       Date:  2016-01-23

5.  [Diagnosis and clinical aspects of gastrointestinal cytomegalovirus diseases in patients with human immunodeficiency virus 1 infection].

Authors:  M Schrappe-Bächer; H M Steffen; G Ollenschläger; B Salzberger; G Fätkenheuer; S Degenhardt; G R Krüger
Journal:  Klin Wochenschr       Date:  1989-11-03

Review 6.  Ileal perforation due to cytomegalovirus infection.

Authors:  A D Meza; S Bin-Sagheer; M J Zuckerman; C A Morales; A Verghese
Journal:  J Natl Med Assoc       Date:  1994-02       Impact factor: 1.798

7.  Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus-infected patients.

Authors:  L Cotte; E Drouet; F Bissuel; G A Denoyel; C Trepo
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

8.  Cytomegalovirus ileitis presenting as massive rectal bleeding in infancy.

Authors:  B Kawimbe; C Bem; P S Patil; H Bharucha
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

9.  Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples.

Authors:  D Michel; E Marre; W Hampl; J Roczkos; S Müller; B Hertenstein; P Kern; B Heymer; B Salzberger; K Arasteh
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

Review 10.  Systematic review: cytomegalovirus infection in inflammatory bowel disease.

Authors:  Hiroshi Nakase; Kayoko Matsumura; Takuya Yoshino; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 6.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.